Thank You!
Please check your email.

The FDA Wants Your Thoughts on Reclassifying Cannabis

  • Comments

This month, the Food and Drug Administration (FDA) is asking Americans for their opinions on whether or not cannabis should be reclassified under international law, Forbes reports. As we are all aware cannabis is currently classified as a Schedule I drug under the Controlled Substances Act of 1970. This means that there is no recognized medical value and it’s nearly impossible to conduct research on. Under international law, involved nations are engaged in treaties where they promise not to legalize cannabis. There is now a chance that this could change.

The World Health Organization (WHO) under the UN is preparing to review the current international status of cannabis, cannabidiol aka CBD, and of course THC. In the US, the FDA is asking for public comments on the issue of reclassifying cannabis prior to its meeting with the UN. People will have until April 23rd to comment. The FDA is looking for the public’s opinions on the “abuse potential” of cannabis, as well as its medical use.

The WHO will then meet in June to go over their findings and determine whether or not cannabis should be reclassified. Last year, the WHO determined that CBD was not only not dangerous, but that it was medically useful. If cannabis were reclassified on an international scale, this would make any push to legalize cannabis throughout the US a lot more likely to be successful. You can post your comments to the FDA here.

Perhaps this will lead to the end of cannabis prohibition?

Source: Forbes

Image Source: USA Today

Will this move by the WHO lead to the end of cannabis prohibition? Can we trust the FDA to make the right decision? Tell us in the comments!